Discovery of N-(2-aryl-cyclohexyl) substituted spiropiperidines as a novel class of GlyT1 inhibitors
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (2) , 349-353
- https://doi.org/10.1016/j.bmcl.2005.09.075
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Glycine transporters: essential regulators of neurotransmissionTrends in Biochemical Sciences, 2005
- N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectivesPsychopharmacology, 2005
- D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophreniaBiological Psychiatry, 2005
- The therapeutic potential of glycine transporter-1 inhibitorsExpert Opinion on Investigational Drugs, 2004
- Glycine transporter I inhibitor, N-Methylglycine (sarcosine), added to antipsychotics for the treatment of schizophreniaPublished by Elsevier ,2004
- Recent progress in the use of glycine transporter-1 inhibitors for the treatment of central and peripheral nervous system diseasesExpert Opinion on Therapeutic Patents, 2004
- High-dose glycine added to olanzapine and risperidone for the treatment of schizophreniaBiological Psychiatry, 2004
- ALX 5407: A Potent, Selective Inhibitor of the hGlyT1 Glycine TransporterMolecular Pharmacology, 2001
- The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of SchizophreniaNeuropsychopharmacology, 1999
- Modulation of N -methyl- d -aspartate receptor function by glycine transportProceedings of the National Academy of Sciences, 1998